Lost Money on Canopy Growth Corporation (CGC)? Contact Levi & Korsinsky to Join Class Action Before June 3, 2025 — Neutral
CGC Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=151310&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

Lost Money on Viatris Inc. (VTRS)? Join Class Action Before June 3, 2025 - Contact Levi & Korsinsky — Neutral
VTRS Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151309&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025 — Neutral
WST Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151312&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADTRAN Holdings, Inc. - ADTN — Neutral
ADTN GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ: ADTN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. - URGN — Neutral
URGN GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

WASHINGTON , June 2, 2025 /PRNewswire/ -- Cogent Communications Holdings, Inc. (NASDAQ: CCOI) (the "Company" or "Cogent") today announced that two of its wholly owned subsidiaries, Cogent Communications Group, LLC (f/k/a Cogent Communications Group, Inc.) ("Cogent Group") and Cogent Finance, Inc. (the "Co-Issuer" and, together with Cogent Group, the "Issuers"), intend to commence an offering of $600.0 million aggregate principal amount of senior secured notes due 2032 (the "Notes") to be offered and sold only to persons reasonably believed to be "qualified institutional buyers" in an unregistered offering pursuant to Rule 144A under the U.S. Securities Act of 1933, as …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT — Neutral
FLGT GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Here's Why You Should Hold Cigna Stock in Your Portfolio for Now — Positive
CI Zacks Investment Research — June 02, 2025CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

Should You Buy Paylocity Stock Despite its 7% Dip in 3 Months? — Positive
PCTY Zacks Investment Research — June 02, 2025PCTY's strong Q3, expanding AI-powered tools and a steady client base present a compelling entry point in the stock for investors.

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma — Neutral
ZBIO GlobeNewsWire — June 02, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zenas To Contact Him Directly To Discuss Their Options

Moderna: Vaccine Approval (Finally!) Provides A Reason To Be Cheerful — Positive
MRNA Seeking Alpha — June 02, 2025Moderna's new COVID vaccine approval targets a broader high-risk population, but the market remains skeptical due to limited revenue prospects and ongoing losses. Management is pivoting to cost-cutting, pipeline focus, and realistic revenue guidance after overreaching post-pandemic and burning through cash on speculative projects. Despite leadership changes at HHS and FDA and loss of government funding, Moderna could outperform 2025 guidance if vaccination rates and combo shots gain traction.

TSMC's Supply Chain Deterrence Supports China-U.S. Peace — Negative
TSM Seeking Alpha — June 02, 2025TSMC has evolved into the keystone of the global order, in an era where power is defined by semiconductors. As the West retools for autonomy, TSMC becomes the thread stitching peace, tech, and deterrence into one fabric. China may contest borders, but it can't destroy global interdependence; TSMC's dispersion strategy binds allies faster than adversaries can decouple from world order dynamics.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Photronics, Inc. - PLAB — Neutral
PLAB GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apple Inc. - AAPL — Neutral
AAPL GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apple Inc. (“Apple” or the “Company”) (NASDAQ: AAPL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN — Neutral
BHVN GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Final Trades: Freeport-McMoran, Cheniere Energy, Box and FTAI Aviation — Neutral
FCX FTAI LNG CNBC Television — June 02, 2025The Investment Committee give you their top stocks to watch for the second half.

Disney is laying off several hundred employees globally, source says — Negative
DIS Reuters — June 02, 2025Walt Disney is laying off several hundred employees globally in teams including marketing for film and television, publicity, and casting and development, a source familiar with the matter said on Monday.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hallador Energy Company - HNRG — Neutral
HNRG GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hallador Energy Company (“Hallador” or the “Company”) (NASDAQ: HNRG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

PepsiCo's International Business Shines: Can It Reignite Performance? — Positive
PEP Zacks Investment Research — June 02, 2025PEP's international momentum, led by strong beverage sales, localization and supply chain investments, fuels optimism despite U.S. softness and FX headwinds.

Innodata vs. SoundHound: Which AI Stock Has More Upside Potential? — Positive
INOD SOUN Zacks Investment Research — June 02, 2025INOD and SOUN are riding the AI wave with surging sales, but their risk-reward profiles tell two very different stories.
